AI Pathology Analysis System Market to Hit $290 Million by 2031, Accelerating with a 16.2% CAGR | Visiopharm, PathAI, Aiforia, Indica Labs

LOS ANGELES, United States: QY Research has recently published a research report titled, "AI Pathology Analysis System - Market Insights, Industry Share, Sales Projections, and Demand Outlook 2024-2030" assessing various factors impacting its trajectory. The global AI Pathology Analysis System market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global AI Pathology Analysis System market.

The global market for AI Pathology Analysis System was estimated to be worth US$ 103 million in 2024 and is forecast to a readjusted size of US$ 290 million by 2031 with a CAGR of 16.2% during the forecast period 2025-2031.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.in/request-sample/service-software-ai-pathology-analysis-system-market-insights-industry-share-sales-projections-and-demand-outlook-2024-2030

The research study includes great insights about critical market dynamics, including drivers, restraints, trends, and opportunities. It also includes various types of market analysis such as competitive analysis, manufacturing cost analysis, manufacturing process analysis, price analysis, and analysis of market influence factors. It is a complete study on the global AI Pathology Analysis System market that can be used as a set of effective guidelines for ensuring strong growth in the coming years. It caters to all types of interested parties, viz. stakeholders, market participants, investors, market researchers, and other individuals associated with the AI Pathology Analysis System business.

Competitive Analysis

Leading players of the global AI Pathology Analysis System market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global AI Pathology Analysis System market. Furthermore, the report offers two separate market forecasts - one for the production side and another for the consumption side of the global AI Pathology Analysis System market. It also provides useful recommendations for new as well as established players of the global AI Pathology Analysis System market.

Details of AI Pathology Analysis System Market Segmentation: -

Key Players Mentioned in the Global AI Pathology Analysis System Market Research Report:

Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics

Segment by Type

On-premises
Cloud-based

Segment by Application

Hospital
Clinic
Others

The segmental analysis section of the report includes a thorough research study on key type and application segments of the global AI Pathology Analysis System market. All of the segments considered for the study are analyzed in quite some detail on the basis of market share, growth rate, recent developments, technology, and other critical factors. The segmental analysis provided in the report will help players to identify high-growth segments of the global AI Pathology Analysis System market and clearly understand their growth journey.

Regional segmentation is an essential part of the AI Pathology Analysis System research report. It analyzes the various regions that the market is segmented on the basis of and evaluates the various influencers. Changing political scenarios, impact of national budgets, governing polices, and importance given to global policies by certain regions and countries has also been discussed in this part of the AI Pathology Analysis System research report.

Report Objectives

(1) Analyzing the size of the global AI Pathology Analysis System market on the basis of value and volume

(2) Accurately calculating the market shares, consumption, and other vital factors of different segments of the global AI Pathology Analysis System market

(3) Exploring key dynamics of the global AI Pathology Analysis System market

(4) Highlighting important trends of the global AI Pathology Analysis System market in terms of production, revenue, and sales

(5) Deeply profiling top players of the global AI Pathology Analysis System market and showing how they compete in the industry

(6) Studying manufacturing processes and costs, product pricing, and various trends related to them

(7) Showing the performance of different regions and countries in the global AI Pathology Analysis System market

(8) Forecasting the market size and share of all segments, regions, and the global market.

Market Forecasting

For long-term market forecasting, our researchers used technological market models, whereas econometric models were used for short-term market forecasting. These models are basically based on an amalgamation of studies related to business principles, economic outlook, regulatory frameworks, and technology landscape. We used a bottom-up approach for market estimation to ensure minimum errors. Use of a bottom-up approach is also critical for providing a deep understanding of the concerned industry.

We considered the following parameters for market forecasting. The market impact of these parameters was quantified and assigned weights to with the help of weighted average analysis.

(A) Current capacity and expected capacity additions up to 2031

(B) Expected developments and regulatory scenarios

(C) Supply versus price trends and raw material scenarios

(D) Current and expected impact of market drivers and restraints

Unlock Exclusive Market Insights - Customize Your Research Report Now! https://www.qyresearch.in/report-details/2638597/AI-Pathology-Analysis-System---Market-Insights

Table of Contents

1 Market Overview
1.1 AI Pathology Analysis System Product Introduction
1.2 Global AI Pathology Analysis System Market Size Forecast (2020-2031)
1.3 AI Pathology Analysis System Market Trends & Drivers
1.3.1 AI Pathology Analysis System Industry Trends
1.3.2 AI Pathology Analysis System Market Drivers & Opportunity
1.3.3 AI Pathology Analysis System Market Challenges
1.3.4 AI Pathology Analysis System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Competitive Analysis by Company
2.1 Global AI Pathology Analysis System Players Revenue Ranking (2024)
2.2 Global AI Pathology Analysis System Revenue by Company (2020-2025)
2.3 Key Companies AI Pathology Analysis System Manufacturing Base Distribution and Headquarters
2.4 Key Companies AI Pathology Analysis System Product Offered
2.5 Key Companies Time to Begin Mass Production of AI Pathology Analysis System
2.6 AI Pathology Analysis System Market Competitive Analysis
2.6.1 AI Pathology Analysis System Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by AI Pathology Analysis System Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pathology Analysis System as of 2024)
2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
3.1 Introduction by Type
3.1.1 On-premises
3.1.2 Cloud-based
3.2 Global AI Pathology Analysis System Sales Value by Type
3.2.1 Global AI Pathology Analysis System Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global AI Pathology Analysis System Sales Value, by Type (2020-2031)
3.2.3 Global AI Pathology Analysis System Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global AI Pathology Analysis System Sales Value by Application
4.2.1 Global AI Pathology Analysis System Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global AI Pathology Analysis System Sales Value, by Application (2020-2031)
4.2.3 Global AI Pathology Analysis System Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
5.1 Global AI Pathology Analysis System Sales Value by Region
5.1.1 Global AI Pathology Analysis System Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global AI Pathology Analysis System Sales Value by Region (2020-2025)
5.1.3 Global AI Pathology Analysis System Sales Value by Region (2026-2031)
5.1.4 Global AI Pathology Analysis System Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America AI Pathology Analysis System Sales Value, 2020-2031
5.2.2 North America AI Pathology Analysis System Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe AI Pathology Analysis System Sales Value, 2020-2031
5.3.2 Europe AI Pathology Analysis System Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific AI Pathology Analysis System Sales Value, 2020-2031
5.4.2 Asia Pacific AI Pathology Analysis System Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America AI Pathology Analysis System Sales Value, 2020-2031
5.5.2 South America AI Pathology Analysis System Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa AI Pathology Analysis System Sales Value, 2020-2031
5.6.2 Middle East & Africa AI Pathology Analysis System Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions AI Pathology Analysis System Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions AI Pathology Analysis System Sales Value, 2020-2031
6.3 United States
6.3.1 United States AI Pathology Analysis System Sales Value, 2020-2031
6.3.2 United States AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.3.3 United States AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe AI Pathology Analysis System Sales Value, 2020-2031
6.4.2 Europe AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China AI Pathology Analysis System Sales Value, 2020-2031
6.5.2 China AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.5.3 China AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan AI Pathology Analysis System Sales Value, 2020-2031
6.6.2 Japan AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea AI Pathology Analysis System Sales Value, 2020-2031
6.7.2 South Korea AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia AI Pathology Analysis System Sales Value, 2020-2031
6.8.2 Southeast Asia AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia AI Pathology Analysis System Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India AI Pathology Analysis System Sales Value, 2020-2031
6.9.2 India AI Pathology Analysis System Sales Value by Type (%), 2024 VS 2031
6.9.3 India AI Pathology Analysis System Sales Value by Application, 2024 VS 2031

7 Company Profiles
7.1 Visiopharm
7.1.1 Visiopharm Profile
7.1.2 Visiopharm Main Business
7.1.3 Visiopharm AI Pathology Analysis System Products, Services and Solutions
7.1.4 Visiopharm AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.1.5 Visiopharm Recent Developments
7.2 PathAI
7.2.1 PathAI Profile
7.2.2 PathAI Main Business
7.2.3 PathAI AI Pathology Analysis System Products, Services and Solutions
7.2.4 PathAI AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.2.5 PathAI Recent Developments
7.3 Aiforia
7.3.1 Aiforia Profile
7.3.2 Aiforia Main Business
7.3.3 Aiforia AI Pathology Analysis System Products, Services and Solutions
7.3.4 Aiforia AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.3.5 Aiforia Recent Developments
7.4 Indica Labs
7.4.1 Indica Labs Profile
7.4.2 Indica Labs Main Business
7.4.3 Indica Labs AI Pathology Analysis System Products, Services and Solutions
7.4.4 Indica Labs AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.4.5 Indica Labs Recent Developments
7.5 aetherAI
7.5.1 aetherAI Profile
7.5.2 aetherAI Main Business
7.5.3 aetherAI AI Pathology Analysis System Products, Services and Solutions
7.5.4 aetherAI AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.5.5 aetherAI Recent Developments
7.6 Proscia
7.6.1 Proscia Profile
7.6.2 Proscia Main Business
7.6.3 Proscia AI Pathology Analysis System Products, Services and Solutions
7.6.4 Proscia AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.6.5 Proscia Recent Developments
7.7 Mindpeak
7.7.1 Mindpeak Profile
7.7.2 Mindpeak Main Business
7.7.3 Mindpeak AI Pathology Analysis System Products, Services and Solutions
7.7.4 Mindpeak AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.7.5 Mindpeak Recent Developments
7.8 Techcyte
7.8.1 Techcyte Profile
7.8.2 Techcyte Main Business
7.8.3 Techcyte AI Pathology Analysis System Products, Services and Solutions
7.8.4 Techcyte AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.8.5 Techcyte Recent Developments
7.9 Qritive
7.9.1 Qritive Profile
7.9.2 Qritive Main Business
7.9.3 Qritive AI Pathology Analysis System Products, Services and Solutions
7.9.4 Qritive AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.9.5 Qritive Recent Developments
7.10 Deepathology
7.10.1 Deepathology Profile
7.10.2 Deepathology Main Business
7.10.3 Deepathology AI Pathology Analysis System Products, Services and Solutions
7.10.4 Deepathology AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.10.5 Deepathology Recent Developments
7.11 Franklin.ai
7.11.1 Franklin.ai Profile
7.11.2 Franklin.ai Main Business
7.11.3 Franklin.ai AI Pathology Analysis System Products, Services and Solutions
7.11.4 Franklin.ai AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.11.5 Franklin.ai Recent Developments
7.12 Roche Diagnostics
7.12.1 Roche Diagnostics Profile
7.12.2 Roche Diagnostics Main Business
7.12.3 Roche Diagnostics AI Pathology Analysis System Products, Services and Solutions
7.12.4 Roche Diagnostics AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.12.5 Roche Diagnostics Recent Developments
7.13 Flagship
7.13.1 Flagship Profile
7.13.2 Flagship Main Business
7.13.3 Flagship AI Pathology Analysis System Products, Services and Solutions
7.13.4 Flagship AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.13.5 Flagship Recent Developments
7.14 Dedalus Group
7.14.1 Dedalus Group Profile
7.14.2 Dedalus Group Main Business
7.14.3 Dedalus Group AI Pathology Analysis System Products, Services and Solutions
7.14.4 Dedalus Group AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.14.5 Dedalus Group Recent Developments
7.15 Ibex Medical Analytics
7.15.1 Ibex Medical Analytics Profile
7.15.2 Ibex Medical Analytics Main Business
7.15.3 Ibex Medical Analytics AI Pathology Analysis System Products, Services and Solutions
7.15.4 Ibex Medical Analytics AI Pathology Analysis System Revenue (US$ Million) & (2020-2025)
7.15.5 Ibex Medical Analytics Recent Developments

8 Industry Chain Analysis
8.1 AI Pathology Analysis System Industrial Chain
8.2 AI Pathology Analysis System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 AI Pathology Analysis System Sales Model
8.5.2 Sales Channel
8.5.3 AI Pathology Analysis System Distributors

9 Research Findings and Conclusion

10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

About Us:

QYResearch is a leading global market research and consulting company established in 2007. With over 17 years' experience and professional research team in various cities over the world QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability.

Contact US

QY RESEARCH, INC.
17890 CASTLETON STREET
SUITE 369, CITY OF INDUSTRY
CA - 91748, UNITED STATES OF AMERICA
Web - https://www.qyresearch.com
Tel: +91-8669986909
Email- ankit@qyresearch.com

This release was published on openPR.